LivaNova PLC has grown revenue 11% a year over three years and 7.6% a year over five. Revenue growth, 3-year annual rate: +11% (Medical Devices median +12%). Revenue growth, 5-year rate: +7.6%, growth has picked up over the last three years. Years of annual history on file: 13, FY2012 to FY2025, as filed.

LIVNLivaNova PLC

Healthcare

$76.39+39% 1Y

$76.39

$49.5752 weeks$85.43

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +12% year on year, but earnings down −187% year on year.

1 good, 1 to watch, 1 neutral

Revenue trend+12% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +8% a year.

Earnings trend−187% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction−0.6 points operating

Trailing-twelve-month operating margin, 12.8% now against 13.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is LIVN growing?

LivaNova PLC has grown revenue 11% a year over three years and 7.6% a year over five.

+11%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +7.6%
Revenue growth, 5-year rate · +11% over three · growth has picked up over the last three years
Years of annual history on file: 13
Years of annual history on file · FY2012 to FY2025, as filed

Details›